TLR7 and lymphoma: Therefore, we chose to use R848, which binds selectively to mouse TLR7, to develop a syngeneic murine lymphoma model to investigate whether TLR7 agonism can enhance the efficacy of anti-CD20 antibodies by priming of T-cell responses.